CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Beginning balance, value at Dec. 31, 2022	$ 759,714	$ 4	$ 5,649,972	$ (8,917,896)	$ (19,732)	$ (2,527,938)
Beginning balance shares at Dec. 31, 2022	759,713,808	3,800
Issuance of common shares and warrants in private placement	$ 9,554		742,289			751,843
Issuance of common shares and warrants in private placement, shares	9,554,192
Net loss				(824,299)		(824,299)
Other comprehensive income					19,732	19,732
Ending balance, value at Jun. 30, 2023	$ 769,268	$ 4	6,392,261	(9,742,195)		(2,580,662)
Ending balance shares at Jun. 30, 2023	769,268,000	3,800
Beginning balance, value at Mar. 31, 2023	$ 762,388	$ 4	5,985,034	(9,147,734)	(14,938)	(2,415,246)
Beginning balance shares at Mar. 31, 2023	762,388,000	3,800
Issuance of common shares and warrants in private placement	$ 6,880		407,227			414,107
Issuance of common shares and warrants in private placement, shares	6,880,000
Net loss				(594,461)		(594,461)
Other comprehensive income					14,938	14,938
Ending balance, value at Jun. 30, 2023	$ 769,268	$ 4	6,392,261	(9,742,195)		(2,580,662)
Ending balance shares at Jun. 30, 2023	769,268,000	3,800
Beginning balance, value at Dec. 31, 2023	$ 770,833	$ 4	9,676,656	(12,517,978)	(942)	(2,071,427)
Beginning balance shares at Dec. 31, 2023	770,833,296	3,800
Issuance of common shares for services	$ 4,040		685,529			689,569
Beginning balance shares	4,040,000
Fair value of options issued to officers and directors for services			1,823,136			1,823,136
Fair value of common shares and warrants issued for refunds	$ 160		41,391			41,551
Beginning balance shares	160,000
Issuance of common shares and warrants as loan incentive	$ 144		20,695			20,839
Beginning balance shares	144,000
Issuance of common shares to acquire technology	$ 76,800		10,579,200			10,656,000
Beginning balance shares	76,800,000
Shares issued (retained) by Findit Inc's shareholders in merger with Findit, Inc.	$ 104,553		7,214,041			7,318,594
Beginning balance shares	104,552,804
Net loss				(4,258,586)		(4,258,586)
Other comprehensive income					1,560	1,560
Ending balance, value at Jun. 30, 2024	$ 956,530	$ 4	30,040,648	(16,776,564)	618	14,221,236
Ending balance shares at Jun. 30, 2024	956,530,100	3,800
Beginning balance, value at Mar. 31, 2024	$ 956,530	$ 4	29,799,102	(15,670,436)	99	15,085,299
Beginning balance shares at Mar. 31, 2024	956,530,100	3,800
Issuance of common shares for services			67,833			67,833
Fair value of options issued to officers and directors for services			172,854			172,854
Issuance of common shares and warrants as loan incentive			859			859
Net loss				(1,106,128)		(1,106,128)
Other comprehensive income					519	519
Ending balance, value at Jun. 30, 2024	$ 956,530	$ 4	$ 30,040,648	$ (16,776,564)	$ 618	$ 14,221,236
Ending balance shares at Jun. 30, 2024	956,530,100	3,800

BIOREGENX, INC. 10-Q